Strategic Partnerships Single Cell Discoveries has recent multi-party collaborations including MLM Medical Labs, Genovis AB, Immunewatch, and participation in PERSIST-SEQ. These alliances indicate a proactive partner-first approach and openness to integrating with downstream service providers, clinical labs, and biotech platforms, presenting growth opportunities through co-marketing, integrated service offerings, and referral channels.

End-to-End TCR The launch and promotion of an end-to-end TCR single-cell sequencing solution leveraging 10x Genomics technology highlights a clear value proposition in immune profiling and clonal analysis. This creates upsell and cross-sell potential with clients seeking turnkey immune repertoire insights, including processing, bioinformatics, and interpretive consulting.

Global CRO Focus Positioned as a leading CRO for single-cell, spatial, and bulk transcriptomics with global reach, there is opportunity to target biopharma and health system customers seeking scalable, specialized transcriptomics capabilities, especially for complex disease programs and translational research pipelines.

Certifications & Credibility Being recognized as a European Certified Service Provider for BioSkryb Genomics ResolveServices enhances trust with potential European clients and big pharma partners, suggesting a sales angle focused on quality assurance, compliance, and standardized workflows.

Growth Signals Active expansion through partnerships and R&D in multi-omics and spatial transcriptomics signals ongoing investment and capability enhancement. This creates opportunities to engage with customers on advanced, high-value projects such as multi-omic integrations and spatial analyses to differentiate in competitive bids.